INSMED Inc (INSM) Financial Statements (2026 and earlier)

Company Profile

Business Address 700 US HIGHWAY 202/206
BRIDGEWATER, NJ 08807
State of Incorp. VA
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,433,826780,4471,148,280716,782532,756487,429
Cash and cash equivalent555,030482,3741,074,036716,782532,756487,429
Short-term investments878,796298,07374,244   
Receivables52,01241,18929,71324,35116,56219,232
Inventory, net of allowances, customer advances and progress billings98,57883,24869,92267,00949,59228,313
Inventory98,57883,24869,92267,00949,59228,313
Other undisclosed current assets37,24524,17925,46828,89823,98220,220
Total current assets:1,621,661929,0631,273,383837,040622,892555,194
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization18,27320,98523,6979,25610,33415,256
Operating lease, right-of-use asset17,25718,01721,89433,30532,94637,673
Property, plant and equipment80,05265,38456,49152,95553,95360,180
Intangible assets, net (including goodwill)194,762199,814204,866209,91949,26153,682
Goodwill136,110136,110136,110136,110  
Intangible assets, net (excluding goodwill)58,65263,70468,75673,80949,26153,682
Other undisclosed noncurrent assets93,22696,57476,104101,03326,76920,314
Total noncurrent assets:403,570400,774383,052406,468173,263187,105
TOTAL ASSETS:2,025,2311,329,8371,656,4351,243,508796,155742,299
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:285,209214,987182,117125,030106,25172,699
Employee-related liabilities28,58125,59119,140
Accounts payable73,03365,39350,46135,78442,85313,184
Accrued liabilities98,19867,14244,68660,66537,80740,375
Other undisclosed accounts payable and accrued liabilities113,97882,45286,970   
Debt2,9612,6101,21760912,55612,261
Other liabilities      280
Other undisclosed current liabilities9,3588,0326,9099,527  
Total current liabilities:297,528225,629190,243135,166118,80785,240
Noncurrent Liabilities
Long-term debt and lease obligation1,127,4461,182,3391,154,886602,132392,286384,777
Long-term debt, excluding current maturities1,103,3821,155,3131,125,250566,588356,318335,940
Finance lease, liability24,06427,02629,63614,10314,71319,529
Liabilities, other than long-term debt153,81198,75875,34095,7429,17810,608
Other liabilities4993,1459,38720,0749,17810,608
Operating lease, liability9,11211,01314,85321,44121,25529,308
Business combination, contingent consideration, liability144,20084,60051,10075,668  
Other undisclosed noncurrent liabilities161,067155,034148,015   
Total noncurrent liabilities:1,442,3241,436,1311,378,241697,874401,464395,385
Total liabilities:1,739,8521,661,7601,568,484833,040520,271480,625
Equity
Equity, attributable to parent285,379(331,923)87,951410,468275,884261,674
Common stock1,7941,4801,3571,1871,028897
Additional paid in capital4,645,7913,113,4872,782,4162,673,5562,105,2521,797,286
Accumulated other comprehensive income (loss)(2,289)(745)756968193(10)
Accumulated deficit(4,359,917)(3,446,145)(2,696,578)(2,265,243)(1,830,589)(1,536,499)
Total equity:285,379(331,923)87,951410,468275,884261,674
TOTAL LIABILITIES AND EQUITY:2,025,2311,329,8371,656,4351,243,508796,155742,299

Income Statement (P&L) ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues363,707305,208245,358188,461164,413136,467
Cost of revenue(174,712)(91,558)(55,126)(50,408)(39,872)(24,212)
Cost of product and service sold(85,742)(65,573)(55,126)(44,152)(39,872)(24,212)
Gross profit:188,995213,650190,232138,053124,541112,255
Operating expenses(1,067,247)(923,276)(668,355)(513,147)(389,773)(347,500)
Other undisclosed operating income   20,802   
Operating loss:(878,252)(709,626)(457,321)(375,094)(265,232)(235,245)
Nonoperating income (expense)53,33643,9885,142(3,156)2,1089,390
Investment income, nonoperating53,30742,13211,0811741,7039,921
Other nonoperating income (expense)291,856(5,939)(3,330)405(531)
Interest and debt expense(84,913)(81,694)(26,446)(58,162)(29,564)(27,705)
Loss from continuing operations before equity method investments, income taxes:(909,829)(747,332)(478,625)(436,412)(292,688)(253,560)
Other undisclosed income (loss) from continuing operations before income taxes(236)320(1,526)   
Loss from continuing operations before income taxes:(910,065)(747,012)(480,151)(436,412)(292,688)(253,560)
Income tax expense (benefit)(3,707)(2,555)(1,383)1,758(1,402)(777)
Loss from continuing operations:(913,772)(749,567)(481,534)(434,654)(294,090)(254,337)
Loss before gain (loss) on sale of properties:(434,654)(294,090)(254,337)
Net loss available to common stockholders, diluted:(913,772)(749,567)(481,534)(434,654)(294,090)(254,337)

Comprehensive Income ($ in thousands)

9/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(913,772)(749,567)(481,534)(434,654)(294,090)(254,337)
Comprehensive loss:(913,772)(749,567)(481,534)(434,654)(294,090)(254,337)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(1,544)(1,501)(212)775203(1)
Comprehensive loss, net of tax, attributable to parent:(915,316)(751,068)(481,746)(433,879)(293,887)(254,338)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: